P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions
- 1 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 2 (4), 183-192
- https://doi.org/10.1039/b919728a
Abstract
Determination of the patient-specific response to antiplatelet agents facilitates proper dosing for both acute and chronic prophylaxis. “Closed” systems (with or without flow) may fail to predict pharmacological potency in situations where platelets rapidly accumulate under flow conditions at a site of thrombosis (“Open” systems). Using an 8-channel microfluidic flow assay of human whole blood with corn trypsin inhibitor (± PPACK) perfused over focal zones of collagen, dose-response curves were measured for pharmacological agents at a wall shear rate of 210 s−1. The P2Y1inhibitor MRS 2179 (IC50 = 0.233 ± 0.132 μM) and P2Y12inhibitor2-MeSAMP (IC50 = 2.558 ± 0.799 μM) were potent blockers of secondary platelet accumulation under flow, while the P2X1inhibitor (NF 449) and apyrase failed to reduce platelet accumulation. MRS 2179 and 2-MeSAMP had undetectable effects on initial platelet adhesion to collagen. Numerical simulation of convective-diffusive transport and apyrase-mediated catalyticdegradation of ADP indicated that ultra-high concentrations of apyrase (∼2000 U mL−1) would be required to have the same effect under flow as much lower concentrations (1 U mL−1) currently used in closed systems (aggregometry or cone-and-plate viscometer). This is the first evaluation of IC50 values for P2Y12 and P2Y1antagonists under controlled flow conditions. Evaluation of antiplatelet agents in open flow systems demonstrates that inhibition of either ADP by apyrase or antagonism of P2X1signaling had no inhibitory effect on platelet accumulation. This technique provides a platform for rapidly investigating effects of antithrombotic therapies simultaneously in a model injury system.Keywords
This publication has 45 references indexed in Scilit:
- The P2Y12 Antagonists, 2-Methylthioadenosine 5′-Monophosphate Triethylammonium Salt and Cangrelor (ARC69931MX), Can Inhibit Human Platelet Aggregation through a Gi-independent Increase in cAMP LevelsOnline Journal of Public Health Informatics, 2009
- Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear‐resistance of platelet aggregatesJournal of Thrombosis and Haemostasis, 2008
- Interactions between Multiple Cell Types in Parallel Microfluidic Channels: Monitoring Platelet Adhesion to an Endothelium in the Presence of an Anti-Adhesion DrugAnalytical Chemistry, 2008
- Microfluidic devices for studies of shear-dependent platelet adhesionLab on a Chip, 2008
- A membrane-based microfluidic device for controlling the flux of platelet agonists into flowing bloodLab on a Chip, 2008
- Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flowBlood, 2008
- Matrix Protein Microarrays for Spatially and Compositionally Controlled Microspot Thrombosis under Laminar FlowBiophysical Journal, 2006
- Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotypeBlood, 2003
- Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brainJCI Insight, 2002
- Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane)Analytical Chemistry, 1998